Avantor, Inc. (NYSE:AVTR) Shares Acquired by The Manufacturers Life Insurance Company

The Manufacturers Life Insurance Company grew its position in Avantor, Inc. (NYSE:AVTR) by 653.0% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,174,736 shares of the company’s stock after purchasing an additional 5,354,678 shares during the quarter. The Manufacturers Life Insurance Company owned approximately 0.91% of Avantor worth $159,740,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Boston Partners boosted its holdings in shares of Avantor by 2.2% in the first quarter. Boston Partners now owns 28,561,802 shares of the company’s stock valued at $729,298,000 after acquiring an additional 624,369 shares during the period. Canada Pension Plan Investment Board grew its holdings in shares of Avantor by 6.8% during the second quarter. Canada Pension Plan Investment Board now owns 22,927,325 shares of the company’s stock worth $486,059,000 after buying an additional 1,463,695 shares during the last quarter. 1832 Asset Management L.P. grew its holdings in shares of Avantor by 1,634.9% during the second quarter. 1832 Asset Management L.P. now owns 8,530,118 shares of the company’s stock worth $180,839,000 after buying an additional 8,038,451 shares during the last quarter. Robeco Schweiz AG raised its stake in Avantor by 5.0% during the 2nd quarter. Robeco Schweiz AG now owns 6,006,985 shares of the company’s stock valued at $127,348,000 after acquiring an additional 287,717 shares during the last quarter. Finally, CCLA Investment Management raised its stake in Avantor by 8.7% during the 2nd quarter. CCLA Investment Management now owns 5,128,504 shares of the company’s stock valued at $109,624,000 after acquiring an additional 408,360 shares during the last quarter. Institutional investors and hedge funds own 95.08% of the company’s stock.

Avantor Stock Performance

NYSE AVTR opened at $21.01 on Wednesday. The business has a 50 day moving average price of $23.65 and a 200 day moving average price of $23.79. The company has a market capitalization of $14.30 billion, a P/E ratio of 45.67, a PEG ratio of 2.52 and a beta of 1.35. Avantor, Inc. has a 1-year low of $19.59 and a 1-year high of $28.00. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.54 and a quick ratio of 1.06.

Insider Buying and Selling at Avantor

In other Avantor news, CAO Steven W. Eck sold 3,525 shares of the company’s stock in a transaction dated Thursday, September 5th. The shares were sold at an average price of $25.06, for a total value of $88,336.50. Following the sale, the chief accounting officer now owns 29,544 shares of the company’s stock, valued at $740,372.64. This represents a 10.66 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 1.30% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of research analysts have recently issued reports on the company. UBS Group dropped their target price on Avantor from $30.00 to $29.00 and set a “buy” rating on the stock in a report on Tuesday, October 8th. Wells Fargo & Company dropped their price objective on shares of Avantor from $30.00 to $28.00 and set an “overweight” rating on the stock in a research note on Monday, October 28th. Robert W. Baird cut their price objective on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a research report on Monday, October 28th. Barclays lowered their target price on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating on the stock in a report on Friday, October 25th. Finally, Royal Bank of Canada reissued an “outperform” rating and set a $34.00 price target on shares of Avantor in a report on Thursday, September 26th. Three research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat.com, Avantor has an average rating of “Moderate Buy” and a consensus price target of $27.57.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.